☸️ SAIMSARA — Public Sessions

To comprehensively map the existing evidence on inhaled insulin, synthesizing findings on its glycemic efficacy, safety, pharmacokinetic/pharmacodynamic properties, patient acceptability, and role in special populations, in order to delineate its current clinical utility and identify critical knowledge gaps. The review uses 82 references and builds its evidence map from 168 original studies with 1087562 total participants/sample observations (topic-deduplicated ΣN). Overall, the evidence indicates that inhaled technosphere insulin offers a clinically viable, ultra-rapid prandial option that is…

The glymphatic system is emerging as a shared biological link between sleep, vascular injury, neurodegeneration, inflammation, and impaired brain waste clearance. Built from more than 1,000 original studies, this review maps the mechanisms, imaging biomarkers, disease associations, therapeutic signals, and major uncertainties—offering the most complete view of where glymphatic science stands and what it may soon change in clinical practice.

Post-SSRI sexual dysfunction is emerging as a distinct and potentially enduring iatrogenic syndrome marked by erectile dysfunction, genital anesthesia, loss of libido, and profound effects on quality of life. This review maps the clinical evidence, mechanistic signals, treatment attempts, and major research gaps—showing what is already known, what remains uncertain, and why the full evidence landscape matters.

Built on 1,032 linked references, this review maps the full exoskeleton evidence landscape—from stroke and spinal cord injury rehabilitation to occupational support, mobility assistance, human augmentation, control systems, and real-world adoption. The full read reveals where exoskeletons genuinely improve function and reduce physical burden, where benefits remain task- and user-dependent, and which barriers still prevent broad clinical and industrial implementation.

EVAR may succeed in the operating room, but its durability is decided years later through surveillance, endoleak detection, sac behavior, and timely reintervention. This review maps the full evidence—from imaging and compliance failures to rupture risk and personalized follow-up—making the complete read valuable for anyone managing long-term EVAR outcomes.

Benign prostatic hyperplasia may be driven as much by metabolic dysfunction, inflammation, frailty, and lifestyle as by the prostate itself. This review maps the strongest human and experimental evidence—from HDL and fatty liver disease to immune markers, microbiome pathways, and emerging preventive targets—making the full read valuable for anyone seeking the complete prevention landscape.

Built on 810 linked references, this review maps the evidence on Ebola virus disease — from vaccines and monoclonal antibodies to relapse, viral persistence, survivor sequelae, diagnostics, outbreak control, and hidden system failures — making the full read valuable for anyone who wants the whole Ebola evidence landscape in one place.

PCSK9 is no longer just an LDL-receptor story: this review maps 642 references on its role across lipid lowering, cardiovascular outcomes, inflammation, thrombosis, metabolism, kidney disease, neurobiology, pregnancy, and cancer immunity. The full read shows where PCSK9 inhibition is already clinically strong, where pleiotropic effects may open new therapeutic fields, and where safety or access barriers still limit translation.

Multilingual children are often assessed and educated inside systems built around monolingual norms, creating real risks of misdiagnosis, lost heritage-language potential, and unequal educational support. This review shows where multilingualism becomes a clinical challenge, an educational resource, and a misunderstood developmental advantage worth reading in full.

This review condenses 4,522 original studies and 4.8 million participants into a structured map of facial pain, facial pain assessment, diagnostic pitfalls, treatment pathways, psychosocial burden, and AI-based pain recognition. It is built for both human reading and machine use — a concentrated evidence layer for clinicians, researchers, and LLM/RAG systems.

Falsified and substandard medicines are not a marginal pharmacy problem — they are a global public-health threat spanning antimalarials, antibiotics, anticancer agents, cardiovascular drugs, online semaglutide, benzodiazepines, supplements, and emerging synthetic opioids. Unlock the full review to explore 75 mapped references, 103 original studies, prevalence signals up to 59.5%, toxic contamination risks, detection technologies, and the supply-chain gaps that still leave patients exposed.

Eagle syndrome is not just an elongated styloid process on imaging — it is a clinical-anatomic compression disorder that can mimic craniofacial pain, dental disease, neuralgia, headache, syncope, stroke, or venous outflow obstruction. Unlock the full read to explore the diagnostic pitfalls, vascular warning signs, treatment patterns, and why styloidectomy remains the most consistently supported definitive option.